Altrus

Anonymous

Guest
Hard to believe it's been two plus years...

"We look forward to introducing our tissue sealing device, the Altrus Thermal Tissue Fusion System, to the surgical community," noted Joseph J. Corasanti, President and CEO of CONMED. "We believe the current marketplace for energy based instruments approximates $1.5 billion, and while our initial revenue goals for Altrus in 2011 are modest at $5 - $10 million, we expect Altrus® to be a contributor to our long-term growth prospects."

Even harder to believe how far from original sales estimates Altrus has fallen.
 






Hard to believe it's been two plus years...

"We look forward to introducing our tissue sealing device, the Altrus Thermal Tissue Fusion System, to the surgical community," noted Joseph J. Corasanti, President and CEO of CONMED. "We believe the current marketplace for energy based instruments approximates $1.5 billion, and while our initial revenue goals for Altrus in 2011 are modest at $5 - $10 million, we expect Altrus® to be a contributor to our long-term growth prospects."

Even harder to believe how far from original sales estimates Altrus has fallen.

When did it launch and what were its sales last year?
 


















It's like we are trying to sell a Zenith tube-based TV in the flat screen market. SD vs HD. ..... you get the picture.

In a culture of fear, loathing and intimidation from so called Sales Management....puleeze. This place is wack. if you are looking to come to work here you need your head examined. If you do come to work here you are stupid.